Challenges and pragmatic approach towards Hemophilia inhibit
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
One of the important complications in hemophilia management is inhibitor development. Inhibitors tend to pose a great challenge in terms of increased risk of hospitalization, morbidity & mortality. Also, since the behaviour of Inhibitors is slightly erratic and difficult to interpret. With the latest advances in the field of Hemophilia, the management of Inhibitors could be improved by today's new learnings and thereby provides a better opportunity of the standard of care for people with Hemophilia.

Takeda and PlexusMD are presenting you with a free, unique webinar on Challenges and pragmatic approach towards Hemophilia inhibitor Management in India with Dr. Sreenath, key Member of Association Physician of India.

Key areas of the topic:

~ Inhibitors in Hemophilia
~ The incidence and prevalence of inhibitors in hemophilia A
~ Burden of Inhibitors
~ Inhibitors Development
~ Clinical Diagnosis of Inhibitors
~ Inhibitor Management Strategies

Join us on Saturday, 19th September, 5pm onward: https://pxmd.co/tVVGE
Preview
Like
Comment
Share